Special Issue "Functional Role of Cytokines in Cancer and Chronic Inflammation"
Deadline for manuscript submissions: 31 January 2024 | Viewed by 1005
2. Department of Biomedical Research, University of Bern, Freiburgstrasse 15, CH-3010 Bern, Switzerland
Interests: cytokines; signaling pathway; checkpoint proteins; tumour biology
2. Ministry of Healthcare, A.I. Yevdokimov Moscow State University of Medicine and Dentistry of the Ministry of Healthcare of the Russian Federation, Moscow, Russia
3. Department of Cell Biology and Histology, School of Biology, Lomonosov Moscow State University, Moscow, Russia
Interests: cytokines; inflammation; immune cells; cell migration; atherosclerosis
Cytokines form a diverse group of signaling proteins which are secreted by a wide range of cell types, including immunocompetent cells, and contribute to various aspects of inflammation, such as cell damage, metabolic alterations, angiogenesis, cell haemoattraction and migration. Beyond their more apparent role in acute inflammation, these molecules are responsible for a longstanding and less-studied chronic inflammatory response that is now known to drive a number of diseases, most notably a wide range of cancers, cardiovascular disease, and autoimmune and neurodegenerative disorders. Cytokines, which are involved in chronic inflammation, have specific effects on the cross-talk between various cell types and thus form a microenvironment that can either promote or block disease progression.
Over the last 30 years, the role of cytokines and their receptors have been extensively investigated in both cancer progression and anti-cancer therapy. However, more effective immunotherapies require the cytokine profiling of each tumour type and comprehensive understanding of tumour biology. In cardiovascular disease, cytokines are an important part of the atherogenic environment and thus appear as potential targets in atherosclerosis prevention and treatment.
The articles published in this Special Issue will cover all aspects of fundamental and translational cytokine research for better understanding of cancer development and chronic inflammation-related diseases. This includes pathogenesis, progression and cytokine-specific therapeutic approaches.
Dr. Elizaveta Fasler-Kan
Dr. Daria M. Potashnikova
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- cytokine antagonists
- signaling pathways
- chronic inflammation
- cancer development
- cancer progression
- cytokine therapy